Bioisosteric replacement is a technique of transforming a compound by exchanging a group of atoms for a different group that is similar in terms of its physicochemical properties. The underlying purpose of this modification is the enhancement of a certain biological or chemical property, such as affinity towards a given target, pharmacodynamics, pharmacokinetics, or the exploration of new, unknown scaffolds. Although fundamentally simple, the method has been successfully applied in numerous drug design projects and has led to some spectacular results, such as the discovery of prontosil (its active metabolite, sulfanilamide, is a bioisostere of *para*-aminobenzoic acid)\[[@b1]\] and pindolol (a nonselective beta blocker, developed from propranolol by replacing the naphthalene moiety with indole). Given its capabilities, the full potential of bioisosterism has not yet been utilized, especially in the field of serotonin receptor ligands; to the best of our knowledge, only four reports in the literature explicitly applying the strategy of bioisosteric replacement.\[[@b2]--[@b5]\]

In May 2013, approximately 22 000 unique ligands with known activity against any serotonin receptor were annotated in the ChEMBL database.\[[@b6]\] Despite this quantity and the relatively high diversity within this set, the vast majority of compounds contain two typical pharmacophore features characteristic of serotonergic ligands: an aromatic system and a polarizable nitrogen atom. Following the classification of 5-HT receptor ligands described in the literature, ten key structural classes of ligands can be highlighted: tryptamines, phenylalkylamines, aminotetralines, aporphines, ergolines, arylpiperazines, piperidines, tricycles, indole and sulfonamide derivatives;\[[@b7]--[@b16]\] these classes were used in this research.

To apply the concept of bioisosterism to serotonin receptors, we conducted a detailed exploration of the bioisosteric data available. The methodology of using substitution matrices, as demonstrated here for 5-HT~6~R, allows the identification of the most frequent and most efficient replacements in terms of biological activity and provides valuable suggestions for modifications to existing ligands for the rational design of new, potent and selective ligands for serotonin receptors.

The source of the compounds was the ChEMBL database version 16 (May 2013). To preserve the coherence of the data, only compounds with defined *K*~i~ values or equivalent (IC~50~, assumed to be 2×*K*~i~; p*K*~i~ and pIC~50~ values were converted to *K*~i~), as assayed on human cloned, rat cloned or native receptors, were considered. In the case of multiple data for a single ligand, the *K*~i~ value and data against human receptors were preferred; a median value was used in the case of multiple biological results. Among the 14 members of the 5-HTR family, two were rejected: 5-HT~3~R because it is an ion channel and 5-HT~5B~R due to an insufficient number of ligands to perform a comprehensive analysis. The set of 5-HT~6~R ligands fetched from the ChEMBL database (2277 compounds) was enriched by data extracted from approximately 40 patents (2529 compounds). For each compound acting on the remaining 5-HTR subtypes (5-HT~1A~, 5-HT~1B~, 5-HT~1D~, 5-HT~1E~, 5-HT~1F~, 5-HT~2A~, 5-HT~2B~, 5-HT~2C~, 5-HT~4~, 5-HT~5A~, 5-HT~6~, 5-HT~7~), all classic bioisosteric replacements implemented in Pipeline Pilot\[[@b17]\] (divided into six classes: ring, amide, carbonyl, halogen and hydroxyl substitutions and ring modifications) were applied. The input structures and duplicates were removed from the original collections, leading to 12 sets of unique bioisosteres. Each compound was then queried against all other sets (regardless of target). Finding the same structure in the ligand and bioisostere set indicated that bioisostere replacement between those repositories exists. This procedure was repeated for all bioisostere collections and led to the identification of all bioisosteres between all targets as well as within the chemical space of single receptor (self-bioisosteres) (Table [1](#tbl1){ref-type="table"}). The collections of bioisosteres belonging to the same class of ligands were gathered into matrices, revealing the amount of positive, neutral and negative substitutions in terms of affinity towards a given target.

###### 

The number of bioisosteres found for different serotonin receptor subtypes.

  Receptor   5-HT~1A~   5-HT~1B~   5-HT~1D~   5-HT~1E~   5-HT~1F~   5-HT~2A~   5-HT~2B~   5-HT~2C~   5-HT~4~   5-HT~5A~   5-HT~6~   5-HT~7~
  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- ---------- --------- ---------
  5-HT~1A~   2053       204        248        27         48         384        60         156        30        34         113       165
  5-HT~1B~   204        316        297        29         51         60         40         64         23        22         75        59
  5-HT~1D~   248        297        378        32         52         72         47         75         31        25         89        66
  5-HT~1E~   27         29         32         26         13         27         18         27         22        19         35        28
  5-HT~1F~   48         51         52         13         61         13         13         13         9         3          27        15
  5-HT~2A~   384        60         72         27         13         1306       288        818        25        61         129       103
  5-HT~2B~   60         40         47         18         13         288        341        282        19        13         59        42
  5-HT~2C~   156        64         75         27         13         818        282        921        25        30         140       105
  5-HT~4~    30         23         31         22         9          25         19         25         130       15         28        19
  5-HT~5A~   34         22         25         19         3          31         13         30         15        39         31        23
  5-HT~6~    113        75         89         35         27         129        59         140        28        31         2180      131
  5-HT~7~    165        59         66         28         15         103        42         105        19        23         131       347

Self-bioisosteres represent the largest portion of the analyzed population of ligands (with the exception of 5-HT~1E~R). Unsurprisingly, the number of self-bioisosteres is proportional to the quantity of ligands (Table [2](#tbl2){ref-type="table"}). The highest rate of self-bioisosteres was observed for the 5-HT~1F~R and 5-HT~6~R, due to enrichment of the original sets retrieved from ChEMBL with patent data (5-HT~6~R) and to exploration of structure---activity relationship studies in a limited number of published papers (5-HT~1F~R). A relatively high number of bioisosteres is also observed for closely related targets (e.g., 5-HT~2~Rs).

###### 

Abundance of types of bioisosteric replacements by class.

  Receptor   Ligands   Bioisosteres   Self-bioisosteres[\[a\]](#tf2-1){ref-type="table-fn"}               Replacement class                     Total
  ---------- --------- -------------- ------------------------------------------------------- ----- ----- ------------------- ------ ---- ----- -------
  5-HT~1A~   6709      293477         0.306                                                   362   142   108                 692    14   735   2053
  5-HT~1B~   1145      50084          0.276                                                   66    44    48                  82     2    74    316
  5-HT~1D~   1319      59318          0.287                                                   68    64    46                  90     2    108   378
  5-HT~1E~   132       5905           0.197                                                   0     0     0                   16     0    10    26
  5-HT~1F~   125       5868           0.488                                                   20    14    0                   6      2    19    61
  5-HT~2A~   3864      167910         0.338                                                   114   18    16                  804    2    352   1306
  5-HT~2B~   1017      44248          0.335                                                   34    8     10                  214    2    73    341
  5-HT~2C~   3019      126863         0.305                                                   56    30    26                  596    2    211   921
  5-HT~4~    532       36453          0.244                                                   8     24    2                   58     0    38    130
  5-HT~5A~   271       8453           0.144                                                   2     2     2                   26     0    7     39
  5-HT~6~    4806      165675         0.454                                                   278   26    142                 1054   2    678   2180
  5-HT~7~    3019      64212          0.242                                                   52    12    24                  154    4    101   347

 Fraction of self-bioisosteres;

 Substitution of the entire ring systems;

 Ring modifications only (e.g., opening, contraction, etc.).

The most frequent replacements for self-bioisosteres are the following: halogen replacements (nearly 50 % of all substitutions), ring modifications, and substitutions. Apparently, the hydroxyl class of substitutions was the least frequently explored within the investigated dataset. The analysis of bioisosteric substitutions for 5-HT~6~R ligands showed two types of substitutions that enhanced activity: 2-substituted pyridine ring substituted by other aromatic systems, especially phenyl (Table [3](#tbl3){ref-type="table"}), and nitrile group, which are interchangeable with any halogen (Figure [1](#fig01){ref-type="fig"}). Moreover, the introduction of sulfonamide (Table [4](#tbl4){ref-type="table"}) and urea increases affinity towards 5-HT~6~R in all cases.

###### 

Affinity of compounds for the 5-HT~6~R, depending on the presence of a 2-pyridine or a phenyl group.

  Compd   R=2-pyridine    R=Ph                                                  Compd   R=2-pyridine                                       
  ------- --------------- ---------------- ---------------- ---------------- -- ------- ---------------- ----------------- --------------- ----------------
          1\[[@b19]\]     --               1\[[@b20]\]      *--*                        --               860\[[@b22]\]     2\[[@b23]\]     *--*
          0.5\[[@b19]\]   --               1\[[@b19]\]      *--*                        --               15750\[[@b22]\]   100\[[@b23]\]   *--*
          100\[[@b21]\]   --               1.58\[[@b21]\]   *--*                        10\[[@b24]\]     --                9.6\[[@b24]\]   *--*
          --              1590\[[@b22]\]   --               974\[[@b23]\]               1054\[[@b25]\]   --                0.5\[[@b26]\]   *--*
          --              2980\[[@b22]\]   --               692\[[@b23]\]               --               25300\[[@b27]\]   --              4940\[[@b27]\]
          --              8360\[[@b22]\]   --               1057\[[@b23]\]              --               45900\[[@b27]\]   --              3790\[[@b27]\]

![All bioisosteric replacements for 5-HT~6~R ligands belonging to A) halogen, B) phenyl, C) hydroxyl, D) amide, and E) carbonyl modifications. The total number of a given replacement is given in the intersection field. The three numbers in parentheses represent the number of replacements that increase (X \_ \_), do not change (\_ X \_) and decrease (\_ \_ X) the affinity. Color code: desirable substitutions (□); substitutions that decrease activity (▪); substitutions that do not influence activity (▪).](cmdc0010-0601-f1){#fig01}

###### 

Affinity of compounds for the 5-HT~6~R, depending on the presence of an amide or a sulfonamide functionality.

  Compd   *K*~i~ \[n[m]{.smallcaps}\]   
  ------- ----------------------------- ----------------
          3981\[[@b28]\]                2512\[[@b28]\]
          4.4\[[@b29]\]                 0.4\[[@b29]\]
          3.0\[[@b29]\]                 0.3\[[@b29]\]

Analogous analysis for 5-HT~1A~R ligands proves that the introduction of 2-pyridine or replacement of the trifluoromethyl group usually leads to increased affinity (see Supporting Information). For 5-HT~2A~R ligands, 2-pyridine, 2-thiophene, nitrile and trifluoromethyl are undesirable, and the removal of a bromo substituent negatively affects the activity. On the contrary, substitutions introducing a bromo group are the most desirable for the modulation of activity towards 5-HT~2C~R. 2-Pyridine, nitrile and iodo should be replaced similarly to other targets. An amide moiety is preferred over a nitrile in potent 5-HT~4~R ligands. For 5-HT~7~R ligands, substitution of phenyl or 2-thiophene increases activity, as does replacement of the amide linker, especially with sulfonamide.\[[@b18]\]

Here, some restrictions were applied to investigate the replacement of groups, with the knowledge that different targets might have different activity thresholds. For each receptor--receptor pair, only substitutions appearing at least five times in the global analysis and with at least twofold more examples of increasing affinity than decreasing (or vice versa) were considered. In general, ring modifications (linearization or expansion) decreased activity towards all targets. Substitution of an amide with a carbonyl moiety in 5-HT~1A~R ligands enhances affinity towards 5-HT~1B~R and 5-HT~1D~R but decreases affinity toward 5-HT~7~R. Transition from amide to sulfonamide or urea shifts activity towards 5-HT~1B~R and 5-HT~1D~R, respectively, in the majority of cases. Conversely, reverse substitution (sulfonamide to amide) in 5-HT~1A~R ligands enhances the activity of compounds against subtypes 1D and 2A. Exchanging a fluoro with a chloro group in 5-HT~6~R ligands increases the activity for receptors 5-HT~1A~, 5-HT~1B~ and 5-HT~1D~, whereas a chloro group in 5-HT~1A~R ligands replaced with other halogens leads to decreased affinity towards 1B, 1D and 2C subtypes. All ring modifications of 5-HT~1A~R ligands decrease the affinity for 5-HT~1B~R, 5-HT~1D~R and 5-HT~1F~R and 5-HT~2~R.

We observed that the modification of 5-HT~1B~R ligands results in highly potent 5-HT~1D~R compounds, as shown with 16 different substitutions. Moreover, ring modifications in these ligands increase activity towards 5-HT~1F~R, 5-HT~2~Rs and 5-HT~7~R subtypes. Ring contraction of 5-HT~1D~, 5-HT~1E~ and 5-HT~1F~ receptors ligands leads to more active 5-HT~7~R ligands as well; however, ring expansion in 5-HT~1D~R ligands decreases activity towards 5-HT~2~Rs. A bromo group in place of other halogens in 5-HT~2A~R ligands enhances the affinity towards 5-HT~2B~R. An identical effect is achieved if a fluoro group is substituted with another halogen; this replacement generates compounds that are active toward 5-HT~2C~R and 5-HT~7~R.

In summary, the concept of bioisosteric matrices has been applied to analyze the chemical space of ligands of the serotonin receptors. The results revealed that in many cases, the given ligand is a bioisostere of a compound active towards a different member of the 5-HTR family. The number of such cases allows the assumption that bioisosteric replacement could be a viable method for discovering novel, promising ligands for serotonin receptors. This statement is also supported by a large number (30 % of the population on average) of self-bioisosteres. The size of this set results from extensive structure--activity relationship studies, exploring a significant number of substitutions. However, the trend to replace terminal and relatively simple groups indicates that the full potential of the bioisosteric substitution has yet to be revealed. All bioisosteres analyzed in this study are available from the authors upon request.

The study was partially supported by the Polish-Norwegian Research Programme operated by the National Centre for Research and Development under the Norwegian Financial Mechanism 2009--2014 in the frame of Project PLATFORMex (Pol-Nor/198887/73/2013).

Supporting information for this article is available on the WWW under <http://dx.doi.org/10.1002/cmdc.201402563>.
